Premanifest Huntington's Disease Extension Study II: Creatine Safety & Tolerability (Pre-CREST-2X)

This study has been completed.
National Institutes of Health (NIH)
Information provided by (Responsible Party):
Steven M. Hersch, Massachusetts General Hospital Identifier:
First received: August 4, 2011
Last updated: January 10, 2014
Last verified: January 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2013
  Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: January 10, 2014